The eFlow®rapid nebuliser system with new eBase Controller is suitable for the treatment of a wide range of diseases of the lower airways. It stands for efficient, safe and fast inhalation treatment, combined with even more advantages:
1 Naehrig S et al. Eur J Med Res 2011; 16(2): 63-6
Aerosol characteristics of the eFlow®rapid nebuliser system
MMADa): 4,6 µm
Respirable Fractiona) < 5 µm: 55 %
Aerosol Output Rateb): 0,5 g/min
Aerosol data according to ISO 27427; nebulised medium: Salbutamol 2.5 ml. Measured values may vary depending on the medication used. Recommended fill volume: see package leaflet for the medication.
a) Measurement with Next Generation Pharmaceutical Impactor (NGI) at 23 °C and 50% relative humidity. Inspiratory flow: 15 l/min
b) Measurement with breathing simulator at 23 °C and 50 % relative humidity. 500 ml breathing volume, breathing frequency 15 cycles/minute, sinusoidal breathing pattern, inhalation/exhalation ratio 1:1 (with adults, may vary in children).
For more technical information please see the Instructions for use.
Click on the video links below to find out more about the topics listed. Please always follow the respective instructions for use.
Service is essential to keep medical equipment operational and safe. Our Nordic service team consists of experienced service technicians stationed across the Nordic countries. Our service technicians are ready to take on your every service need.”